Groen HJM - Search Results

1

Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.

Oude Nijhuis CSM, Vellenga E, Daenen SMGJ, van der Graaf WTA, Gietema JA, Groen HJM, Kamps WA, de Bont ESJM. Oude Nijhuis CSM, et al. Among authors: groen hjm. Intensive Care Med. 2003 Dec;29(12):2157-2161. doi: 10.1007/s00134-003-2026-2. Epub 2003 Oct 16. Intensive Care Med. 2003. PMID: 14569424 Clinical Trial.

2

Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer.

Veldhuis GJ, Willemse PH, Sleijfer DT, van der Graaf WT, Groen HJ, Limburg PC, Mulder NH, de Vries EG. Veldhuis GJ, et al. J Clin Oncol. 1995 Oct;13(10):2585-93. doi: 10.1200/JCO.1995.13.10.2585. J Clin Oncol. 1995. PMID: 7595711 Clinical Trial.

3

Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study.

van Gameren MM, Willemse PH, Mulder NH, Limburg PC, Groen HJ, Vellenga E, de Vries EG. van Gameren MM, et al. Blood. 1994 Sep 1;84(5):1434-41. Blood. 1994. PMID: 8068939 Free article. Clinical Trial.

4

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.

de Jong RS, Mulder NH, Uges DR, Kaul S, Winograd B, Sleijfer DTh, Groen HJ, Willemse PH, van der Graaf WT, de Vries EG. de Jong RS, et al. Br J Cancer. 1997;75(11):1660-6. doi: 10.1038/bjc.1997.282. Br J Cancer. 1997. PMID: 9184183 Free PMC article. Clinical Trial.

5

Effects of gemcitabine on renal function in patients with non-small cell lung cancer.

Gietema JA, Groen HJ, Meijer S, Smit EF. Gietema JA, et al. Eur J Cancer. 1998 Jan;34(1):199-202. doi: 10.1016/s0959-8049(97)00354-7. Eur J Cancer. 1998. PMID: 9624259

6

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.

de Jong RS, Mulder NH, Uges DR, Sleijfer DT, Höppener FJ, Groen HJ, Willemse PH, van der Graaf WT, de Vries EG. de Jong RS, et al. Br J Cancer. 1999 Feb;79(5-6):882-7. doi: 10.1038/sj.bjc.6690141. Br J Cancer. 1999. PMID: 10070885 Free PMC article. Clinical Trial.

7

99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumours.

Bakker M, van der Graaf WT, Piers DA, Franssen EJ, Groen HJ, Smit EF, Kool W, Hollema H, Müller EA, De Vries EG. Bakker M, et al. Anticancer Res. 1999 May-Jun;19(3B):2349-53. Anticancer Res. 1999. PMID: 10472354

8

A young female with an endodermal sinus tumor in a pericardial localized cyst.

van der Graaf WT, Groen HJ, van der Werf TS, Meuzelaar JJ, Sleijfer DT. van der Graaf WT, et al. Acta Oncol. 2000;39(2):244-6. doi: 10.1080/028418600430879. Acta Oncol. 2000. PMID: 10859021 No abstract available.

9

The blood-brain barrier and oncology: new insights into function and modulation.

Bart J, Groen HJ, Hendrikse NH, van der Graaf WT, Vaalburg W, de Vries EG. Bart J, et al. Cancer Treat Rev. 2000 Dec;26(6):449-62. doi: 10.1053/ctrv.2000.0194. Cancer Treat Rev. 2000. PMID: 11139374 Review.

10

P-glycoprotein at the blood-brain barrier and analysis of drug transport with positron-emission tomography.

Hendrikse NH, Bart J, de Vries EG, Groen HJ, van der Graaf WT, Vaalburg W. Hendrikse NH, et al. J Clin Pharmacol. 2001 Jul;41(S7):48S-54S. J Clin Pharmacol. 2001. PMID: 11452728 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters